Associations between colorectal cancer screening and glycemic control in people with diabetes, Boston, Massachusetts, 2005-2010

Preventing Chronic Disease

Volumn 8, Issue 4, 2011, Pages

  Wilkinson, Joanne E ^a   Culpepper, Larry ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; COLORECTAL TUMOR; COMPARATIVE STUDY; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MALE; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SIGMOIDOSCOPY; UNITED STATES;

BLOOD GLUCOSE; COLORECTAL NEOPLASMS; DIABETES MELLITUS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SIGMOIDOSCOPY;

EID: 84863908289     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pelucchi C, Negri E, Talamini R, Levi F, Glacosa A, Crispo A, et al. Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer 2010;46(10):1866-72.
2. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA. The association of diabetes mellitus and colorectal cancer risk: the Multiethnic Cohort. Br J Cancer 2010;103(1):120-6.
3. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of colon cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011;128(3):635-43.
4. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009;15(41):5141-8.
5. Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007;16(8):1543-6.
6. Vinikoor LC, Long MD, Keku TO, Martin CF, Galanko JA, Sandler RS. The association between diabetes, insulin use, and colorectal cancer among whites and African Americans. Cancer Epidemiol Biomarkers Prev 2009;18(4):1239-42.
7. Tsugane S, Inoue M. Insulin resistance and cancer: epidemiological evidence. Cancer Sci 2010;101(5):1073-9.
8. Berster JM, Göke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 2008;114(1):84-98.
9. Mainous AG 3rd, Koopman RJ, Gill JM, Baker R, Pearson WS. Relationship between continuity of care and diabetes control: evidence from the third National Health and Nutrition Examination Survey. Am J Public Health 2004;94(1):66-70.
10. DeVoe JE, Tillotson CJ, Wallace LS. Usual source of care as a health insurance substitute for U.S. adults with diabetes? Diabetes Care 2009;32(6):983-9.
11. Doubeni CA, Laiyemo AO, Young AC, Klabunde CN, Reed G, Field TS, et al. Primary care, economic barriers to healthcare, and use of colorectal cancer screening tests in Medicare enrollees over time. Ann Fam Med 2010;8(4):299-307.
12. Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML. Trends in colorectal cancer test use in the Medicare population, 1998-2005. Am J Prev Med 2009;37(1):1-7.
13. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening among adults aged 50-75 years: United States, 2008. MMWR Morb Mortal Wkly Rep 2010;59(26):808-12.
14. Screening for colorectal cancer. US Preventive Services Task Force; 2008. http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. Accessed July 16, 2010.
15. Fenton JJ, Tancredi DJ, Green P, Franks P, Baldwin LM. Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in Medicare enrollees. J Am Geriatr Soc 2009;57(3):412-8.
16. McBean AM, Yu X. The underuse of screening services among elderly women with diabetes. Diabetes Care 2007;30(6):1466-72.
17. Karathanasi I, Kamposioras K, Cortinovis I, Karampoiki V, Alevizaki P, Dambrosio M, et al. Moving ahead in diabetics' cancer screening; food for thought from the Hellenic experience. Eur J Cancer Care (Engl) 2009;18(3):255-63.
18. Lipscombe LL, Hux JE, Booth GL. Reduced screening mammography among women with diabetes. Arch Intern Med 2005;165(18):2090-5.
19. Stange KC, Fedirko T, Zyzanski SJ, Jaen CR. How do family physicians prioritize delivery of multiple preventive services? J Fam Pract 1994;38(3):231-7.
20. Stange KC, Flocke SA, Goodwin MA, Kelly RB, Zyzanski SJ. Direct observation of rates of preventive service delivery in community family practice. Prev Med 2000;31(2 Pt 1):167-76.
21. Limburg PJ, Vierkant RJ, Fredericksen ZS, Leibson Cl, Rizza RA, Gupta AK, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 2006;101(8):1872-9.
22. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005;14(1):133-7.
23. Rensing KL, Houttuijn Bloemendaal FM, Weijers EM, Richel DJ, Büller HR, Koolwijk P, et al. Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis? Diabetologia 2010;53(5):966-70.
24. Flood A, Strayer L, Schairer C, Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 2010;21(8):1277-84.
25. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97(22):1679-87.